Osteoporosis & Breast Cancer R entered the industry of Family Practice Doctors in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Family Practice Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Family Practice Doctors. The business provides service to the B2C market.
To acquire more information, please contact Larry Truesdale by calling (858) 909-5123 during business hours. You can also write to the business’ Single Location at 3550 General Atomics Court, San Diego, California CA 92121. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Osteoporosis & Breast Cancer R |
Representative: | Larry Truesdale |
Place of Business: | 3550 General Atomics Court, San Diego, CA 92121 |
Contact Number: | (858) 909-5123 |
Type of Service: | Family Practice Doctors |
SIC Number: | 8011 |
NAICS Number: | 621111 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2004 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Osteoporosis & Breast Cancer R is a company operating from San Diego, California providing professional Family Practice Doctors and relevant B2C variables. It was founded in 2004 and registered with the SIC code 8011 as Family Practice Doctors, and with the NAICS code 621111 as Family Practice Doctors.
With a current employee count of 1 to 4, Osteoporosis & Breast Cancer R has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Larry Truesdale at (858) 909-5123 for related queries, or to locate its Single Location using the coordinates 32.894266,-117.237629.
The Single Location can also be found at the street address 3550 General Atomics Court in San Diego, California 92121 and can be engaged online through the company website at , the company Twitter , and Facebook page .